Matthew E. Korenberg, President & Chief Operating: Ligand Pharmaceuticals LGND Sell · Filed 24/05/15

Trade details

Type: Insider sale
Amount: $1,160,321.04
Shares · price: 13,638 sh · $85.08 a share
Held after: 86,783 sh
Stock: Ligand Pharmaceuticals LGND
Person: Matthew E. KorenbergPresident & Chief Operating
Trade date: 24/05/14
Filed: 24/05/15
Days to filing: 1 days

Sold 13.6% of holdings

Share of holding sold: 13.6%

Ligand Pharmaceuticals trades, last 26 weeks

What else happened in Ligand Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/04/14~24/06/13

Matthew E. Korenberg's recent trades

Matthew E. KorenbergPresident & COO
SellLigand Pharmaceuticals
Sell
Ligand Pharmaceuticals
LGND
$720.4K
7,090 sh
$720.4K
Filed 24/09/24
Traded 24/09/23
Matthew E. KorenbergPresident & COO
SellLigand Pharmaceuticals
Sell
Ligand Pharmaceuticals
LGND
$653.2K
6,275 sh
$653.2K
Filed 24/09/24
Traded 24/09/20
Matthew E. KorenbergPresident & COO
SellLigand Pharmaceuticals
Sell
Ligand Pharmaceuticals
LGND
$248.2K
2,481 sh
$248.2K
Filed 24/09/24
Traded 24/09/23
Matthew E. KorenbergPresident & COO
SellLigand Pharmaceuticals
Sell
Ligand Pharmaceuticals
LGND
$20.5K
201 sh
$20.5K
Filed 24/09/24
Traded 24/09/23
Matthew E. KorenbergPresident & COO
SellLigand Pharmaceuticals
Sell
Ligand Pharmaceuticals
LGND
$648.7K
6,177 sh
$648.7K
Filed 24/08/26
Traded 24/08/26